To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SFNTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
465 supporting clones for gene SFN back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ952035 sciatic nerve .a-u 1 to 526 1 to 535   tiling clone,   535/1052
(50 %)
23 diff
(97.9 %id)
CN335049 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 2 to 666 1 to 665       665/665
(100 %)
3 diff
(99.6 %id)
BG750479 eye, normal pigmented retinal epithelium .a-u 96 to 909 1 to 814       814/825
(98 %)
10 diff
(98.8 %id)
BE910042 epithelioid carcinoma, Pancreas .a-u 103 to 324 1 to 222       222/222
(100 %)
0 diff
(100 %id)
BG119265 adenocarcinoma, cell line, Liver .a-u 107 to 344 10 to 247       238/247
(96 %)
6 diff
(97.6 %id)
CA454691   .a-u 111 to 831 1 to 718       718/788
(91 %)
13 diff
(98.4 %id)
BF683349 leiomyosarcoma cell line, uterus .a-u 112 to 880 1 to 772       772/830
(93 %)
29 diff
(96.6 %id)
BF973591 leiomyosarcoma cell line, uterus .a-u 112 to 570 1 to 460       460/460
(100 %)
2 diff
(99.6 %id)
BC023552 Lung, small cell carcinoma .a-u 115 to 1434 1 to 1316 exact available from MGC, AAA   1316/1316
(100 %)
2 diff
(99.9 %id)
AF029082   .a-u 119 to 1433 1 to 1311 exact     1311/1320
(99 %)
4 diff
(99.7 %id)
NM_006142.3   .a-u 119 to 1433 1 to 1315 exact RefSeq, AAA   1315/1315
(100 %)
0 diff
(100 %id)
BM020629 astrocytoma grade IV, cell line, brain .a-u 120 to 728 1 to 609       609/609
(100 %)
6 diff
(99.1 %id)
TI_59386862   .a-u 121 to 728 109 to 716       608/608
(100 %)
5 diff
(99.2 %id)
BG169703 hypernephroma, cell line, Kidney .a-u 122 to 344 1 to 224       224/224
(100 %)
5 diff
(97.8 %id)
BM792473 Ascites, stomach .a-u 123 to 803 1 to 681       681/681
(100 %)
0 diff
(100 %id)
BQ348763 head_neck .a-u 125 to 689 12 to 573       562/581
(96 %)
10 diff
(98.3 %id)
BG740364 skin .a-u 125 to 840 1 to 716       716/718
(99 %)
3 diff
(99.6 %id)
BG681894 skin, squamous cell carcinoma .a-u 126 to 841 1 to 716       716/716
(100 %)
1 diff
(99.9 %id)
BQ222164 epithelioid carcinoma, Pancreas .a-u 126 to 988 1 to 872 E237G E238R E241A A242K P243A ...     872/880
(99 %)
11 diff
(98.8 %id)
BM744184 Ascites, stomach .a-u 126 to 528 1 to 403       403/403
(100 %)
2 diff
(99.6 %id)
BM761220 lymph node, stomach .a-u 126 to 839 1 to 714       714/714
(100 %)
0 diff
(100 %id)
BM761381 lymph node, stomach .a-u 126 to 582 1 to 457       457/457
(100 %)
0 diff
(100 %id)
BM844651 lymph node, stomach .a-u 126 to 635 1 to 510       510/510
(100 %)
0 diff
(100 %id)
BM761530 myeloma .a-u 126 to 575 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BM848111 myeloma .a-u 126 to 643 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BM844023 lymph node, stomach .a-u 127 to 437 1 to 311       311/311
(100 %)
0 diff
(100 %id)
BM844408 lymph node, stomach .a-u 127 to 434 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
BM847398 myeloma .a-u 128 to 641 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
CN335035 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 130 to 658 1 to 528       528/528
(100 %)
2 diff
(99.7 %id)
EL594760 epidermis, skin .a-u 130 to 410 1 to 286       286/290
(98 %)
17 diff
(94.2 %id)
BM017172 astrocytoma grade IV, cell line, brain .a-u 130 to 801 1 to 686       686/686
(100 %)
31 diff
(95.5 %id)
BM044893 carcinoma, cell line, Prostate .a-u 130 to 907 1 to 781       781/781
(100 %)
26 diff
(96.7 %id)
BG336924 leiomyosarcoma cell line, uterus .a-u 131 to 884 1 to 744       744/910
(81 %)
24 diff
(97.4 %id)
BM016717 astrocytoma grade IV, cell line, brain .a-u 131 to 901 1 to 764       764/765
(99 %)
21 diff
(97.3 %id)
TI_59386950   .a-u 131 to 901 94 to 857       764/765
(99 %)
21 diff
(97.3 %id)
TI_59387325   .a-u 131 to 775 93 to 719       627/719
(87 %)
6 diff
(99.2 %id)
TI_59387421   .a-u 131 to 801 99 to 783       685/685
(100 %)
30 diff
(95.7 %id)
CN335043 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 132 to 324 1 to 193       193/193
(100 %)
3 diff
(98.5 %id)
BG120737 adenocarcinoma, cell line, Liver .a-u 132 to 344 1 to 212       212/212
(100 %)
1 diff
(99.6 %id)
BG680999 skin, squamous cell carcinoma .a-u 132 to 778 1 to 648       648/648
(100 %)
6 diff
(99.1 %id)
BM811495 astrocytoma grade IV, cell line, brain .a-u 132 to 999 1 to 876 A235P E237K E238K E241A A242R ...     876/1058
(82 %)
14 diff
(98.7 %id)
BG680853 skin, squamous cell carcinoma .a-u 133 to 903 1 to 773       773/773
(100 %)
5 diff
(99.4 %id)
BM048492 carcinoma, cell line, Prostate .a-u 133 to 918 1 to 792       792/793
(99 %)
12 diff
(98.5 %id)
BM826255 Ascites, stomach .a-u 133 to 508 1 to 376       376/376
(100 %)
14 diff
(96.3 %id)
BQ348764 head_neck .a-u 134 to 634 1 to 502       502/502
(100 %)
10 diff
(98.1 %id)
AW246932 lung, small cell carcinoma .a-u 134 to 587 5 to 466       462/466
(99 %)
6 diff
(98.8 %id)
BM017997 astrocytoma grade IV, cell line, brain .a-u 134 to 830 1 to 709       709/835
(84 %)
48 diff
(94.3 %id)
BM018917 astrocytoma grade IV, cell line, brain .a-u 134 to 796 1 to 675       675/928
(72 %)
29 diff
(96.9 %id)
BM044987 carcinoma, cell line, Prostate .a-u 134 to 748 1 to 610       610/610
(100 %)
9 diff
(98.6 %id)
BM699705 eye, lens .a-u 134 to 641 1 to 508       508/508
(100 %)
2 diff
(99.7 %id)
BE122860 skin .a-u 135 to 439 1 to 305       305/305
(100 %)
0 diff
(100 %id)
CD622036   .a-u 135 to 305 8 to 178       171/178
(96 %)
6 diff
(96.7 %id)
CN335036 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 135 to 889 1 to 756       756/756
(100 %)
6 diff
(99.3 %id)
CN335046 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 135 to 709 1 to 575       575/575
(100 %)
0 diff
(100 %id)
CN335048 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 135 to 825 1 to 691       691/691
(100 %)
0 diff
(100 %id)
BX382021 Placenta Cot 25-normalized .a-u 135 to 1197 1 to 1045 F179L E237X     1045/1066
(98 %)
24 diff
(97.8 %id)
BE798546 lung, small cell carcinoma .a-u 135 to 930 19 to 809       791/823
(96 %)
11 diff
(98.7 %id)
BG681282 skin, squamous cell carcinoma .a-u 135 to 826 1 to 689       689/689
(100 %)
4 diff
(99.5 %id)
BG679451 skin, squamous cell carcinoma .a-u 135 to 939 1 to 808 G53W G54R Q55P R56E A57G ...     808/812
(99 %)
4 diff
(99.6 %id)
BG682025 skin, squamous cell carcinoma .a-u 135 to 825 1 to 692       692/692
(100 %)
3 diff
(99.6 %id)
BI333423 cervical carcinoma cell line, cervix .a-u 135 to 344 1 to 210       210/210
(100 %)
0 diff
(100 %id)
BM911141 astrocytoma grade IV, cell line, brain .a-u 135 to 769 11 to 649       639/1102
(57 %)
12 diff
(99.0 %id)
TI_59388578   .a-u 135 to 830 95 to 802       708/834
(84 %)
48 diff
(94.3 %id)
TI_59389593   .a-u 135 to 796 96 to 769       674/927
(72 %)
29 diff
(96.9 %id)
TI_59389983   .a-u 135 to 902 98 to 863       766/766
(100 %)
5 diff
(99.4 %id)
TI_59390660   .a-u 135 to 728 95 to 694       600/600
(100 %)
16 diff
(97.4 %id)
TI_59390800   .a-u 135 to 878 111 to 855       745/746
(99 %)
11 diff
(98.6 %id)
TI_59390823   .a-u 135 to 844 106 to 816       711/711
(100 %)
4 diff
(99.5 %id)
BM686430 eye, eye anterior segment .a-u 135 to 586 9 to 461       453/461
(98 %)
6 diff
(98.7 %id)
TI_153957307   .a-u 135 to 855 77 to 790       714/964
(74 %)
23 diff
(97.7 %id)
X57348   .a-u 135 to 1433 111 to 1407 exact tiling clone, AAA   1297/1407
(92 %)
8 diff
(99.5 %id)
BE207235 lung, small cell carcinoma .a-u 136 to 742 1 to 605       605/605
(100 %)
6 diff
(99.1 %id)
BG333175 large cell carcinoma, lung .a-u 136 to 729 1 to 594       594/594
(100 %)
7 diff
(98.9 %id)
BG677168 skin, squamous cell carcinoma .a-u 136 to 953 1 to 810 G94A V95C C96A D97T T98P ...     810/810
(100 %)
17 diff
(98.0 %id)
BG678223 skin, squamous cell carcinoma .a-u 136 to 915 1 to 773       773/784
(98 %)
26 diff
(96.7 %id)
BG679118 skin, squamous cell carcinoma .a-u 136 to 929 1 to 800       800/800
(100 %)
9 diff
(98.9 %id)
BI085085 astrocytoma grade IV, cell line, brain .a-u 136 to 905 1 to 772       772/772
(100 %)
14 diff
(98.2 %id)
BI334137 cervical carcinoma cell line, cervix .a-u 136 to 344 23 to 231       209/231
(90 %)
6 diff
(97.5 %id)
BM019302 astrocytoma grade IV, cell line, brain .a-u 136 to 902 1 to 765       765/765
(100 %)
5 diff
(99.4 %id)
BM020932 astrocytoma grade IV, cell line, brain .a-u 136 to 728 1 to 599       599/599
(100 %)
16 diff
(97.4 %id)
BM020022 astrocytoma grade IV, cell line, brain .a-u 136 to 878 1 to 744       744/745
(99 %)
11 diff
(98.6 %id)
BM020045 astrocytoma grade IV, cell line, brain .a-u 136 to 844 1 to 710       710/710
(100 %)
4 diff
(99.5 %id)
BQ925454 epidermoid carcinoma, cell line, lung .a-u 136 to 766 1 to 642       642/830
(77 %)
17 diff
(98.0 %id)
BU542087 carcinoma, cell line, Prostate .a-u 136 to 994 1 to 864 E241A A242R P243L Q244P E245R ...     864/885
(97 %)
8 diff
(99.1 %id)
DN995936 breast cancer, Mammary gland (cancer tissue) .a-u 136 to 623 1 to 488       488/488
(100 %)
5 diff
(99.0 %id)
BG438258 large cell carcinoma, lung .a-u 137 to 944 1 to 808 P164A N166K A173G F176I S177F ...     808/809
(99 %)
17 diff
(97.9 %id)
BG481765 choriocarcinoma, placenta .a-u 137 to 898 1 to 764       764/768
(99 %)
7 diff
(99.1 %id)
BG830196 epithelioid carcinoma cell line, Pancreas .a-u 137 to 467 1 to 330       330/330
(100 %)
2 diff
(99.4 %id)
BI085153 astrocytoma grade IV, cell line, brain .a-u 137 to 751 1 to 625       625/853
(73 %)
28 diff
(96.8 %id)
BI085294 astrocytoma grade IV, cell line, brain .a-u 137 to 749 1 to 612       612/613
(99 %)
7 diff
(98.9 %id)
BM020861 astrocytoma grade IV, cell line, brain .a-u 137 to 773 1 to 646       646/650
(99 %)
26 diff
(96.0 %id)
BM018286 astrocytoma grade IV, cell line, brain .a-u 137 to 827 1 to 691       691/691
(100 %)
4 diff
(99.5 %id)
BM045189 carcinoma, cell line, Prostate .a-u 137 to 906 1 to 785       785/785
(100 %)
53 diff
(93.3 %id)
BQ227862 epithelioid carcinoma, Pancreas .a-u 137 to 987 1 to 863 A173G L174P N175E F176L S177F ...     863/893
(96 %)
38 diff
(95.8 %id)
BE563646 adenocarcinoma, Pancreas .a-u 138 to 714 1 to 580       580/580
(100 %)
8 diff
(98.7 %id)
BG168090 hypernephroma, cell line, Kidney .a-u 138 to 344 1 to 208       208/208
(100 %)
1 diff
(99.6 %id)
BG678850 skin, squamous cell carcinoma .a-u 138 to 942 1 to 807 N166K D211G S212L Y213L K214Q ...     807/812
(99 %)
8 diff
(99.1 %id)
BG680185 skin, squamous cell carcinoma .a-u 138 to 937 1 to 798 V30G E31R K32R G33A E34R ...     798/850
(93 %)
19 diff
(97.8 %id)
BI222813 cervical carcinoma cell line, cervix .a-u 138 to 344 13 to 225       213/225
(94 %)
6 diff
(97.4 %id)
BM560219 astrocytoma grade IV, cell line, brain .a-u 138 to 1007 1 to 874 E238K E241R A242R P243L Q244P ...     874/1086
(80 %)
17 diff
(98.5 %id)
BM560661 astrocytoma grade IV, cell line, brain .a-u 138 to 931 1 to 799       799/1035
(77 %)
10 diff
(99.1 %id)
BM549705 astrocytoma grade IV, cell line, brain .a-u 138 to 937 1 to 805 N185T S186A A203P T207P N226T ...     805/1032
(78 %)
21 diff
(98.0 %id)
BM549713 astrocytoma grade IV, cell line, brain .a-u 138 to 768 28 to 656       629/690
(91 %)
6 diff
(99.2 %id)
BM809762 astrocytoma grade IV, cell line, brain .a-u 138 to 739 25 to 630       606/1383
(43 %)
24 diff
(98.3 %id)
BM563039 astrocytoma grade IV, cell line, brain .a-u 138 to 934 1 to 798       798/997
(80 %)
15 diff
(98.5 %id)
TI_59387821   .a-u 138 to 773 107 to 751       645/649
(99 %)
26 diff
(96.0 %id)
TI_59388873   .a-u 138 to 827 101 to 790       690/690
(100 %)
3 diff
(99.6 %id)
BC000329 Lung, small cell carcinoma .a-u 139 to 1433 1 to 1291 exact available from MGC, AAA   1291/1291
(100 %)
2 diff
(99.9 %id)
BC002995 Lung, small cell carcinoma .a-u 139 to 1433 1 to 1291   available from MGC, AAA   1291/1291
(100 %)
2 diff
(99.9 %id)
BM018226 astrocytoma grade IV, cell line, brain .a-u 139 to 737 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
BM018181 astrocytoma grade IV, cell line, brain .a-u 139 to 808 1 to 692       692/697
(99 %)
70 diff
(90.0 %id)
BM908333 astrocytoma grade IV, cell line, brain .a-u 139 to 928 1 to 792       792/1049
(75 %)
8 diff
(99.3 %id)
BM910410 astrocytoma grade IV, cell line, brain .a-u 139 to 982 1 to 846 N234T A235P E237K E238K E241A ...     846/886
(95 %)
10 diff
(98.9 %id)
BM910872 astrocytoma grade IV, cell line, brain .a-u 139 to 983 1 to 846 S186Q E188R E189G A190G I191H ...     846/1052
(80 %)
22 diff
(98.0 %id)
BM910927 astrocytoma grade IV, cell line, brain .a-u 139 to 797 1 to 658       658/1079
(60 %)
30 diff
(97.3 %id)
BM913737 astrocytoma grade IV, cell line, brain .a-u 139 to 603 1 to 465       465/1181
(39 %)
12 diff
(99.0 %id)
BQ919215 large cell carcinoma, lung .a-u 139 to 915 1 to 777       777/909
(85 %)
7 diff
(99.3 %id)
BQ887556 carcinoma, cell line, Prostate .a-u 139 to 987 1 to 856 D225Y E238K G239K E241G A242E ...     856/882
(97 %)
11 diff
(98.8 %id)
BU152633 carcinoma, cell line, Prostate .a-u 139 to 992 1 to 861 D225Y E237G E238K E241A A242R ...     861/909
(94 %)
21 diff
(97.7 %id)
BU541803 carcinoma, cell line, Prostate .a-u 139 to 869 1 to 742       742/1016
(73 %)
30 diff
(97.1 %id)
BU542261 carcinoma, cell line, Prostate .a-u 139 to 994 1 to 867 D225Y E237X E238K E241R A242R ...     867/874
(99 %)
15 diff
(98.3 %id)
CN335034 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 140 to 900 1 to 761       761/761
(100 %)
4 diff
(99.5 %id)
BG681739 skin, squamous cell carcinoma .a-u 140 to 846 1 to 704       704/704
(100 %)
3 diff
(99.6 %id)
BI085473 astrocytoma grade IV, cell line, brain .a-u 140 to 873 1 to 738       738/738
(100 %)
14 diff
(98.2 %id)
BM560634 astrocytoma grade IV, cell line, brain .a-u 140 to 928 1 to 793       793/1118
(70 %)
15 diff
(98.7 %id)
TI_59388765   .a-u 140 to 808 104 to 794       691/696
(99 %)
69 diff
(90.1 %id)
TI_59388811   .a-u 140 to 737 65 to 661       597/597
(100 %)
1 diff
(99.9 %id)
BM016906 astrocytoma grade IV, cell line, brain .a-u 141 to 787 1 to 657       657/658
(99 %)
13 diff
(98.1 %id)
BM017150 astrocytoma grade IV, cell line, brain .a-u 141 to 721 1 to 596       596/831
(71 %)
26 diff
(96.9 %id)
BM019460 astrocytoma grade IV, cell line, brain .a-u 141 to 908 1 to 765       765/765
(100 %)
15 diff
(98.1 %id)
BM020191 astrocytoma grade IV, cell line, brain .a-u 141 to 675 1 to 539       539/539
(100 %)
9 diff
(98.4 %id)
BM043145 carcinoma, cell line, Prostate .a-u 141 to 864 1 to 722       722/722
(100 %)
11 diff
(98.5 %id)
BM044380 carcinoma, cell line, Prostate .a-u 141 to 767 1 to 630       630/778
(80 %)
30 diff
(96.2 %id)
CA454157   .a-u 141 to 990 1 to 855 N234T A235P E237K E238K E241G ...     855/889
(96 %)
12 diff
(98.7 %id)
TI_59387145   .a-u 141 to 787 46 to 702       657/658
(99 %)
13 diff
(98.1 %id)
TI_59387385   .a-u 141 to 721 95 to 690   AAA   596/821
(72 %)
26 diff
(96.9 %id)
TI_59390145   .a-u 141 to 908 97 to 861       765/765
(100 %)
15 diff
(98.1 %id)
TI_59390972   .a-u 141 to 675 98 to 636       539/539
(100 %)
9 diff
(98.4 %id)
BM709283 eye, optic nerve .a-u 141 to 771 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
BC000995 Placenta, choriocarcinoma .a-u 142 to 1433 1 to 1294 exact tiling clone, available from MGC, AAA   1294/1294
(100 %)
1 diff
(100.0 %id)
CN335038 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 142 to 861 1 to 720       720/720
(100 %)
0 diff
(100 %id)
BG678428 skin, squamous cell carcinoma .a-u 142 to 945 1 to 811 E2K P164H N166T P167H I168P ...     811/885
(91 %)
19 diff
(97.9 %id)
BM549700 astrocytoma grade IV, cell line, brain .a-u 142 to 988 1 to 847 Q244P Q247R S248N     847/878
(96 %)
11 diff
(98.8 %id)
BM550264 astrocytoma grade IV, cell line, brain .a-u 142 to 986 1 to 848 E238K E241A A242R P243L Q244P ...     848/880
(96 %)
11 diff
(98.8 %id)
BM552136 astrocytoma grade IV, cell line, brain .a-u 142 to 1011 1 to 881 A203P S216R D233R N234H G236R ...     881/1019
(86 %)
29 diff
(97.2 %id)
AA315939 colon .a-u 143 to 494 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
BG677094 skin, squamous cell carcinoma .a-u 143 to 914 1 to 764       764/764
(100 %)
19 diff
(97.6 %id)
BG677427 skin, squamous cell carcinoma .a-u 143 to 872 1 to 726       726/726
(100 %)
15 diff
(98.0 %id)
BG680082 skin, squamous cell carcinoma .a-u 143 to 944 1 to 805 R41L N42K L43P L44A S45L ...     805/805
(100 %)
11 diff
(98.7 %id)
BG682223 skin, squamous cell carcinoma .a-u 143 to 865 1 to 723       723/723
(100 %)
4 diff
(99.5 %id)
BG682052 skin, squamous cell carcinoma .a-u 143 to 878 1 to 736       736/736
(100 %)
4 diff
(99.5 %id)
BG741059 skin .a-u 143 to 919 1 to 778       778/778
(100 %)
6 diff
(99.3 %id)
BM017877 astrocytoma grade IV, cell line, brain .a-u 143 to 874 1 to 730       730/730
(100 %)
14 diff
(98.1 %id)
BM908351 astrocytoma grade IV, cell line, brain .a-u 143 to 774 1 to 637       637/1136
(56 %)
9 diff
(99.3 %id)
BM908421 astrocytoma grade IV, cell line, brain .a-u 143 to 1001 1 to 867 N234T A235P E238K E241A A242K ...     867/1052
(82 %)
22 diff
(98.0 %id)
BM909138 astrocytoma grade IV, cell line, brain .a-u 143 to 935 1 to 796       796/1130
(70 %)
18 diff
(98.5 %id)
BM914140 astrocytoma grade IV, cell line, brain .a-u 143 to 907 1 to 769       769/1127
(68 %)
10 diff
(99.2 %id)
BQ641489 eye, normal pigmented retinal epithelium .a-u 143 to 990 1 to 852 D233X N234H A235P G236X E237X ...     852/921
(92 %)
16 diff
(98.3 %id)
BQ958425 carcinoma, cell line, Prostate .a-u 143 to 967 1 to 834 T217P L223V D233R G236R E237G ...     834/908
(91 %)
23 diff
(97.5 %id)
TI_59388454   .a-u 144 to 874 96 to 824       729/729
(100 %)
13 diff
(98.3 %id)
CV570828 cornea, eye .a-u 144 to 751 1 to 608       608/608
(100 %)
0 diff
(100 %id)
CV574569 cornea, eye .a-u 144 to 792 1 to 649       649/649
(100 %)
0 diff
(100 %id)
BG679016 skin, squamous cell carcinoma .a-u 145 to 825 1 to 679       679/679
(100 %)
5 diff
(99.3 %id)
BM706918 eye, optic nerve .a-u 145 to 845 9 to 707       699/708
(98 %)
14 diff
(98.1 %id)
BG674929 skin .a-u 146 to 940 1 to 799 L12S A13G E14R Q15A A16G ...     799/801
(99 %)
14 diff
(98.3 %id)
BG678052 skin, squamous cell carcinoma .a-u 146 to 861 1 to 715       715/715
(100 %)
4 diff
(99.5 %id)
BG680988 skin, squamous cell carcinoma .a-u 146 to 843 1 to 695       695/695
(100 %)
3 diff
(99.6 %id)
BM549551 astrocytoma grade IV, cell line, brain .a-u 146 to 908 1 to 763       763/1155
(66 %)
13 diff
(98.9 %id)
BM551781 astrocytoma grade IV, cell line, brain .a-u 146 to 988 1 to 844 E237G Q247R     844/1122
(75 %)
9 diff
(99.2 %id)
BM051061 eye, normal pigmented retinal epithelium .a-u 147 to 897 1 to 741       741/743
(99 %)
15 diff
(98.0 %id)
BM047215 carcinoma, cell line, Prostate .a-u 147 to 920 1 to 774       774/774
(100 %)
4 diff
(99.5 %id)
TI_45133601   .a-u 147 to 804 62 to 719       658/957
(68 %)
11 diff
(98.9 %id)
BG678334 skin, squamous cell carcinoma .a-u 149 to 767 1 to 617       617/782
(78 %)
16 diff
(98.0 %id)
BI085642 astrocytoma grade IV, cell line, brain .a-u 149 to 423 1 to 274       274/274
(100 %)
1 diff
(99.7 %id)
BI457355 epithelioid carcinoma cell line, Pancreas .a-u 149 to 804 1 to 656       656/955
(68 %)
11 diff
(98.9 %id)
BQ887249 carcinoma, cell line, Prostate .a-u 149 to 928 1 to 787       787/886
(88 %)
10 diff
(98.9 %id)
BQ921122 epidermoid carcinoma, cell line, lung .a-u 149 to 991 1 to 846 E241A A242R P243L Q244P E245R ...     846/902
(93 %)
8 diff
(99.2 %id)
BG679143 skin, squamous cell carcinoma .a-u 150 to 918 1 to 769       769/770
(99 %)
10 diff
(98.8 %id)
BM563640 astrocytoma grade IV, cell line, brain .a-u 151 to 945 1 to 801 E238K E241R A242G P243L Q244P ...     801/871
(91 %)
10 diff
(98.9 %id)
BM552296 astrocytoma grade IV, cell line, brain .a-u 151 to 1027 1 to 885 E237V S248N     885/1050
(84 %)
19 diff
(98.2 %id)
BM551716 astrocytoma grade IV, cell line, brain .a-u 151 to 990 1 to 843 E238R E241R A242G P243S Q244P ...     843/1040
(81 %)
8 diff
(99.3 %id)
BG677905 skin, squamous cell carcinoma .a-u 152 to 944 1 to 803 R41L N42K L43P L44A S45L ...     803/803
(100 %)
19 diff
(97.7 %id)
BE264906 lung, small cell carcinoma .a-u 154 to 849 1 to 689       689/706
(97 %)
14 diff
(98.1 %id)
BE733027 choriocarcinoma, placenta .a-u 154 to 919 1 to 763       763/1085
(70 %)
15 diff
(98.7 %id)
BM016985 astrocytoma grade IV, cell line, brain .a-u 154 to 691 1 to 547       547/773
(70 %)
19 diff
(97.6 %id)
BM550154 astrocytoma grade IV, cell line, brain .a-u 154 to 990 1 to 836 exact     836/1008
(82 %)
10 diff
(99.1 %id)
BG676471 skin, squamous cell carcinoma .a-u 155 to 881 1 to 730       730/730
(100 %)
9 diff
(98.8 %id)
BG677243 skin, squamous cell carcinoma .a-u 155 to 778 1 to 623       623/625
(99 %)
6 diff
(99.1 %id)
BM810453 astrocytoma grade IV, cell line, brain .a-u 155 to 740 23 to 606       584/652
(89 %)
28 diff
(95.8 %id)
TI_59387225   .a-u 155 to 691 59 to 604       546/772
(70 %)
19 diff
(97.6 %id)
BE734249 choriocarcinoma, placenta .a-u 156 to 901 1 to 742       742/743
(99 %)
10 diff
(98.7 %id)
BE730807 choriocarcinoma, placenta .a-u 156 to 905 1 to 745       745/745
(100 %)
9 diff
(98.8 %id)
BE794408 lung, small cell carcinoma .a-u 156 to 927 1 to 762       762/767
(99 %)
14 diff
(98.2 %id)
BE900566 choriocarcinoma, placenta .a-u 156 to 865 1 to 706       706/707
(99 %)
6 diff
(99.2 %id)
BE542511 cervix .a-u 157 to 323 1 to 166       166/170
(97 %)
6 diff
(96.5 %id)
BE279479 choriocarcinoma, placenta .a-u 157 to 852 1 to 698       698/749
(93 %)
19 diff
(97.5 %id)
BE735987 adenocarcinoma, Pancreas .a-u 157 to 927 1 to 758       758/779
(97 %)
22 diff
(97.2 %id)
BE732582 choriocarcinoma, placenta .a-u 157 to 947 1 to 786 D97E P164X S186R H206D L208S ...     786/793
(99 %)
18 diff
(97.8 %id)
W79136 heart .a-u 158 to 605 1 to 452       452/453
(99 %)
11 diff
(97.6 %id)
BF219694 lung, small cell carcinoma .a-u 158 to 697 1 to 540       540/541
(99 %)
1 diff
(99.9 %id)
BE616059 adenocarcinoma, Pancreas .a-u 158 to 918 1 to 751       751/769
(97 %)
23 diff
(97.1 %id)
BE615170 adenocarcinoma, Pancreas .a-u 158 to 930 1 to 764       764/766
(99 %)
15 diff
(98.1 %id)
BM017092 astrocytoma grade IV, cell line, brain .a-u 158 to 775 6 to 609       604/609
(99 %)
6 diff
(99.1 %id)
CN335037 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 159 to 623 1 to 465       465/465
(100 %)
0 diff
(100 %id)
CN335045 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 159 to 793 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BG682467 skin, squamous cell carcinoma .a-u 159 to 725 19 to 605       587/608
(96 %)
46 diff
(92.5 %id)
BM909299 astrocytoma grade IV, cell line, brain .a-u 159 to 782 48 to 671       624/1171
(53 %)
12 diff
(99.0 %id)
BX109990 heart .a-u 161 to 732 1 to 574       574/576
(99 %)
4 diff
(99.4 %id)
BE786565 large cell carcinoma, lung .a-u 162 to 324 1 to 164       164/164
(100 %)
3 diff
(98.2 %id)
BE563248 adenocarcinoma, Pancreas .a-u 164 to 838 5 to 673       669/901
(74 %)
17 diff
(98.2 %id)
BM911111 astrocytoma grade IV, cell line, brain .a-u 164 to 906 1 to 749       749/1052
(71 %)
18 diff
(98.3 %id)
BE279710 choriocarcinoma, placenta .a-u 165 to 769 1 to 611       611/613
(99 %)
10 diff
(98.4 %id)
BE512901 adenocarcinoma cell line, colon .a-u 165 to 860 1 to 702       702/702
(100 %)
13 diff
(98.2 %id)
BE512933 adenocarcinoma cell line, colon .a-u 165 to 633 1 to 465       465/465
(100 %)
10 diff
(97.9 %id)
BE877248 large cell carcinoma, undifferentiated, lung .a-u 168 to 324 1 to 158       158/158
(100 %)
1 diff
(99.4 %id)
BM016848 astrocytoma grade IV, cell line, brain .a-u 179 to 907 1 to 740       740/740
(100 %)
20 diff
(97.3 %id)
BM018358 astrocytoma grade IV, cell line, brain .a-u 179 to 783 1 to 626       626/768
(81 %)
20 diff
(97.4 %id)
BE789792 large cell carcinoma, lung .a-u 180 to 767 1 to 597       597/778
(76 %)
18 diff
(97.7 %id)
TI_59387085   .a-u 180 to 907 58 to 796       739/739
(100 %)
19 diff
(97.5 %id)
TI_59388946   .a-u 180 to 783 96 to 720       625/767
(81 %)
20 diff
(97.4 %id)
M93010 mammary gland .a-u 180 to 1433 1 to 1245 Y120H A242V     1245/1245
(100 %)
29 diff
(97.7 %id)
BQ326016 colon_normal .a-u 181 to 805 1 to 626       626/626
(100 %)
8 diff
(98.8 %id)
BE799040 lung, small cell carcinoma .a-u 181 to 944 42 to 808 T165P N166S I168S R169A L170W ...     767/1161
(66 %)
6 diff
(99.5 %id)
BG680424 skin, squamous cell carcinoma .a-u 182 to 907 1 to 735       735/735
(100 %)
21 diff
(97.2 %id)
BM557712 astrocytoma grade IV, cell line, brain .a-u 182 to 1043 1 to 871 E241A A242R P243A Q244P E245Q ...     871/1073
(81 %)
28 diff
(97.4 %id)
BG677464 skin, squamous cell carcinoma .a-u 188 to 928 1 to 751       751/756
(99 %)
19 diff
(97.5 %id)
TI_1948073830   .a-u 189 to 572 131 to 514       384/411
(93 %)
6 diff
(98.6 %id)
CR541905   .a-u 190 to 936 1 to 747 K77M     747/747
(100 %)
1 diff
(99.9 %id)
CR541926   .a-u 190 to 933 1 to 744       744/744
(100 %)
0 diff
(100 %id)
CV023858 mixed .a-u 190 to 851 1 to 662       662/662
(100 %)
2 diff
(99.7 %id)
BQ349303 head_neck .a-u 193 to 827 1 to 635       635/636
(99 %)
8 diff
(98.8 %id)
BM907961 large cell carcinoma, lung .a-u 200 to 983 24 to 816       793/1079
(73 %)
27 diff
(97.5 %id)
TI_59390502   .a-u 215 to 907 94 to 785       692/692
(100 %)
11 diff
(98.5 %id)
BM019807 astrocytoma grade IV, cell line, brain .a-u 217 to 907 1 to 690       690/690
(100 %)
11 diff
(98.5 %id)
BQ314586 denis_drash .a-u 218 to 847 638 to 9       630/645
(97 %)
0 diff
(100 %id)
BG678467 skin, squamous cell carcinoma .a-u 225 to 940 1 to 719       719/721
(99 %)
9 diff
(98.8 %id)
BQ314584 denis_drash .a-u 226 to 830 615 to 12       604/615
(98 %)
0 diff
(100 %id)
BQ350251 head_neck .a-u 228 to 882 675 to 16       660/675
(97 %)
0 diff
(100 %id)
CK906163 Islets of Langerhans, Pancreas .a-u 243 to 828 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BM016820 astrocytoma grade IV, cell line, brain .a-u 254 to 920 1 to 670       670/672
(99 %)
13 diff
(98.1 %id)
BM909689 astrocytoma grade IV, cell line, brain .a-u 255 to 978 25 to 751       727/1101
(66 %)
24 diff
(97.9 %id)
TI_59387056   .a-u 255 to 920 39 to 707       669/671
(99 %)
13 diff
(98.1 %id)
BM127570 Islets of Langerhans, Pancreas .a-u 259 to 843 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BM126957 Islets of Langerhans, Pancreas .a-u 260 to 813 1 to 554       554/554
(100 %)
0 diff
(100 %id)
TI_1948074008   .a-u 262 to 935 808 to 125       684/1397
(48 %)
0 diff
(100 %id)
BG681908 skin, squamous cell carcinoma .a-u 277 to 931 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BM824967 Ascites, stomach .a-u 286 to 899 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BG982505 colon_normal .a-u 290 to 662 1 to 373       373/373
(100 %)
2 diff
(99.5 %id)
BM817517 Ascites, stomach .a-u 293 to 580 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BE904498 epithelioid carcinoma, Pancreas .a-u 300 to 940 1 to 639       639/905
(70 %)
20 diff
(97.8 %id)
BQ348762 head_neck .a-u 309 to 874 570 to 3       568/570
(99 %)
0 diff
(100 %id)
CD622031   .a-u 311 to 928 1 to 619       619/619
(100 %)
5 diff
(99.2 %id)
BQ227759 epithelioid carcinoma, Pancreas .a-u 318 to 1028 1 to 714       714/952
(75 %)
14 diff
(98.6 %id)
BQ349895 head_neck .a-u 329 to 882 565 to 12       554/565
(98 %)
0 diff
(100 %id)
BG996562 head_neck .a-u 341 to 808 1 to 470       470/470
(100 %)
21 diff
(95.6 %id)
CU445916 epidermis .a-u 344 to 848 529 to 24     Submitted on the opposite strand 506/535
(94 %)
0 diff
(100 %id)
BG680729 skin, squamous cell carcinoma .a-u 352 to 950 1 to 598       598/604
(99 %)
6 diff
(99.1 %id)
BG697512 skin .a-u 352 to 957 1 to 603       603/798
(75 %)
11 diff
(98.7 %id)
BF879472 lung_tumor .a-u 357 to 870 517 to 3     Submitted on the opposite strand 515/517
(99 %)
0 diff
(100 %id)
BI086671 cervix .a-u 357 to 943 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
AA315717 colon .a-u 358 to 769 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BG678365 skin, squamous cell carcinoma .a-u 358 to 967 1 to 612       612/859
(71 %)
17 diff
(98.1 %id)
TI_1948073661   .a-u 363 to 935 709 to 134       576/1350
(42 %)
0 diff
(100 %id)
BM689233 eye, eye anterior segment .a-u 365 to 855 8 to 498       491/498
(98 %)
6 diff
(98.8 %id)
CU452814 epidermis .a-u 366 to 814 469 to 21     Submitted on the opposite strand 449/491
(91 %)
0 diff
(100 %id)
BG996382 head_neck .a-u 371 to 929 1 to 565       565/577
(97 %)
34 diff
(94.2 %id)
CN335042 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 374 to 951 1 to 578       578/578
(100 %)
3 diff
(99.5 %id)
BI021080 marrow .a-u 376 to 877 501 to 11       491/501
(98 %)
0 diff
(100 %id)
BG677715 skin, squamous cell carcinoma .a-u 377 to 987 1 to 614       614/617
(99 %)
12 diff
(98.1 %id)
AW366988 head_neck .a-u 378 to 606 21 to 254       234/254
(92 %)
6 diff
(97.7 %id)
AA158555 Pancreas .a-u 379 to 668 1 to 293       293/293
(100 %)
10 diff
(96.6 %id)
BQ083199 Ascites, stomach .a-u 382 to 725 1 to 344       344/344
(100 %)
4 diff
(98.9 %id)
CD622033   .a-u 389 to 927 1 to 537       537/537
(100 %)
2 diff
(99.7 %id)
BG287782 bladder, transitional cell papilloma, cell line .a-u 392 to 938 1 to 547   AAA   547/1114
(49 %)
2 diff
(99.9 %id)
AW050862 colon, colonic mucosa from 3 patients with Crohn'sdisease .a-u 396 to 859 465 to 1       465/465
(100 %)
5 diff
(99.0 %id)
T28709 greater omentum .a-u 397 to 659 1 to 263       263/263
(100 %)
0 diff
(100 %id)
BF852724 lung_normal .a-u 404 to 757 11 to 365       355/365
(97 %)
6 diff
(98.4 %id)
BQ352582 head_neck .a-u 406 to 726 325 to 6       320/338
(94 %)
0 diff
(100 %id)
BF837642 head_neck .a-u 409 to 877 476 to 9     Submitted on the opposite strand 468/476
(98 %)
0 diff
(100 %id)
BG695947 skin .a-u 410 to 946 1 to 538       538/618
(87 %)
3 diff
(99.6 %id)
BG993128 head_neck .a-u 411 to 868 1 to 460       460/460
(100 %)
23 diff
(95.0 %id)
BI085298 astrocytoma grade IV, cell line, brain .a-u 411 to 944 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BG996561 head_neck .a-u 414 to 718 10 to 315       306/315
(97 %)
6 diff
(98.1 %id)
BG677777 skin, squamous cell carcinoma .a-u 414 to 952 1 to 542       542/873
(62 %)
10 diff
(98.9 %id)
CN335039 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 415 to 870 1 to 458       458/458
(100 %)
6 diff
(98.7 %id)
BF871451 lung_tumor .a-u 418 to 669 262 to 12     Submitted on the opposite strand 251/262
(95 %)
0 diff
(100 %id)
BF871462 lung_tumor .a-u 418 to 645 251 to 24     Submitted on the opposite strand 228/251
(90 %)
0 diff
(100 %id)
BQ315886 colon .a-u 419 to 689 274 to 4       271/274
(98 %)
0 diff
(100 %id)
BQ326023 colon_normal .a-u 420 to 897 476 to 1       476/483
(98 %)
9 diff
(98.2 %id)
CV571013 cornea, eye .a-u 420 to 988 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BF769412 epid_tumor .a-u 422 to 869 454 to 7     Submitted on the opposite strand 448/458
(97 %)
0 diff
(100 %id)
BF858452 prostate_tumor .a-u 422 to 740 330 to 12     Submitted on the opposite strand 319/334
(95 %)
0 diff
(100 %id)
BG116102 duodenal adenocarcinoma, cell line, small intestine .a-u 423 to 940 1 to 518       518/940
(55 %)
3 diff
(99.7 %id)
BE812433 amnion_normal .a-u 436 to 790 356 to 2       355/359
(98 %)
0 diff
(100 %id)
CD622034   .a-u 437 to 1313 881 to 4       878/881
(99 %)
0 diff
(100 %id)
BE715339 head_neck .a-u 452 to 693 253 to 13       241/253
(95 %)
0 diff
(100 %id)
BE715340 head_neck .a-u 452 to 693 260 to 20       241/260
(92 %)
0 diff
(100 %id)
TI_149297051   .a-u 454 to 1433 1068 to 94   AAA   975/977
(99 %)
29 diff
(97.1 %id)
CU450406 epidermis .a-u 463 to 814 378 to 27     Submitted on the opposite strand 352/378
(93 %)
0 diff
(100 %id)
CD622035   .a-u 467 to 1313 853 to 5       849/853
(99 %)
0 diff
(100 %id)
CU443825 epidermis .a-u 467 to 814 374 to 27     Submitted on the opposite strand 348/435
(80 %)
0 diff
(100 %id)
CU447540 epidermis .a-u 469 to 814 372 to 27     Submitted on the opposite strand 346/382
(90 %)
0 diff
(100 %id)
BE293089 adenocarcinoma cell line, colon .a-u 476 to 954 1 to 480       480/505
(95 %)
4 diff
(99.3 %id)
TI_1948074185   .a-u 480 to 935 582 to 126       457/1353
(33 %)
0 diff
(100 %id)
BF852675 lung_normal .a-u 515 to 690 198 to 23     Submitted on the opposite strand 176/198
(88 %)
0 diff
(100 %id)
BI014983 lung_tumor .a-u 524 to 944 416 to 2       415/425
(97 %)
0 diff
(100 %id)
BG291949 bladder, transitional cell papilloma, cell line .a-u 524 to 952 1 to 429       429/961
(44 %)
2 diff
(99.8 %id)
BU185912 ductal carcinoma, cell line, Pancreas .a-u 524 to 1015 21 to 514       494/1302
(37 %)
13 diff
(99.1 %id)
BG291257 bladder, transitional cell papilloma, cell line .a-u 525 to 952 1 to 429       429/1197
(35 %)
6 diff
(99.5 %id)
BG946472 bladder_tumor .a-u 527 to 671 149 to 3       147/149
(98 %)
0 diff
(100 %id)
BU163361 ductal carcinoma, cell line, Pancreas .a-u 527 to 1097 1 to 573       573/861
(66 %)
11 diff
(98.8 %id)
BQ879441 ductal carcinoma, cell line, Pancreas .a-u 527 to 982 1 to 457       457/1081
(42 %)
5 diff
(99.6 %id)
BQ687227 ductal carcinoma, cell line, Pancreas .a-u 527 to 1005 1 to 478       478/1229
(38 %)
7 diff
(99.5 %id)
BU149499 ductal carcinoma, cell line, Pancreas .a-u 527 to 1018 1 to 492       492/950
(51 %)
5 diff
(99.5 %id)
BG676638 skin, squamous cell carcinoma .a-u 528 to 950 1 to 423       423/759
(55 %)
6 diff
(99.3 %id)
BF911231 uterus_tumor .a-u 535 to 825 1 to 291       291/296
(98 %)
17 diff
(94.3 %id)
BM706633 eye, optic nerve .a-u 537 to 1095 1 to 559   fully sequenced,   559/559
(100 %)
7 diff
(98.8 %id)
BF834773 head_neck .a-u 539 to 756 230 to 13     Submitted on the opposite strand 218/247
(88 %)
0 diff
(100 %id)
CD622032   .a-u 542 to 1201 663 to 5       659/663
(99 %)
6 diff
(99.1 %id)
BQ878414 ductal carcinoma, cell line, Pancreas .a-u 544 to 1019 1 to 476       476/982
(48 %)
3 diff
(99.7 %id)
BQ687305 ductal carcinoma, cell line, Pancreas .a-u 544 to 1026 1 to 486       486/1036
(46 %)
9 diff
(99.2 %id)
AW366532 head_neck .a-u 555 to 689 139 to 2       138/139
(99 %)
0 diff
(100 %id)
BF349440 head_neck .a-u 555 to 704 150 to 1       150/154
(97 %)
3 diff
(98.1 %id)
BM707102 eye, eye anterior segment .a-u 558 to 936 1 to 379       379/379
(100 %)
4 diff
(99.0 %id)
TI_149311691   .a-u 571 to 1433 939 to 86   tiling clone, AAA   854/959
(89 %)
18 diff
(98.2 %id)
BG741085 skin .a-u 583 to 964 1 to 381       381/422
(90 %)
8 diff
(98.2 %id)
TI_149300977   .a-u 594 to 1433 905 to 79   AAA   827/977
(84 %)
20 diff
(98.0 %id)
BF916659 uterus_tumor .a-u 608 to 869 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BF917675 uterus_tumor .a-u 608 to 869 262 to 1     Submitted on the opposite strand 262/262
(100 %)
0 diff
(100 %id)
BM824871 Ascites, stomach .a-u 609 to 1007 1 to 399       399/399
(100 %)
0 diff
(100 %id)
BI047875 stomach .a-u 617 to 796 1 to 179       179/179
(100 %)
2 diff
(98.9 %id)
BQ362779 stomach .a-u 617 to 819 213 to 13       201/213
(94 %)
0 diff
(100 %id)
BQ362377 stomach .a-u 622 to 934 125 to 437       313/437
(71 %)
6 diff
(98.7 %id)
BF349744 head_neck .a-u 630 to 885 267 to 12       256/285
(89 %)
0 diff
(100 %id)
BG874403 breast_normal .a-u 632 to 931 1 to 298       298/298
(100 %)
6 diff
(98.0 %id)
BE715461 head_neck .a-u 635 to 867 234 to 3       232/237
(97 %)
0 diff
(100 %id)
BE715583 head_neck .a-u 635 to 884 261 to 13       249/267
(93 %)
0 diff
(100 %id)
BG874386 breast_normal .a-u 639 to 897 259 to 2       258/259
(99 %)
0 diff
(100 %id)
BG874393 breast_normal .a-u 639 to 900 263 to 2       262/263
(99 %)
0 diff
(100 %id)
BE711319 head_neck .a-u 646 to 876 1 to 231       231/231
(100 %)
0 diff
(100 %id)
BI013961 lung_tumor .a-u 654 to 873 14 to 231       218/231
(94 %)
6 diff
(97.5 %id)
AA064692 Pancreas .a-u 659 to 871 1 to 213       213/219
(97 %)
3 diff
(98.7 %id)
TI_149296726   .a-u 665 to 1433 882 to 113   AAA   770/771
(99 %)
26 diff
(96.7 %id)
TI_151741137   .a-u 665 to 1433 858 to 103   AAA   756/821
(92 %)
25 diff
(97.0 %id)
BG876817 head_neck .a-u 667 to 838 7 to 178       172/203
(84 %)
3 diff
(98.6 %id)
BF851685 lung_normal .a-u 675 to 878 18 to 225       208/225
(92 %)
6 diff
(97.4 %id)
BE715531 head_neck .a-u 679 to 889 1 to 210       210/210
(100 %)
12 diff
(94.3 %id)
BM550119 astrocytoma grade IV, cell line, brain .a-u 682 to 1433 799 to 35   AAA Submitted on the opposite strand 765/1030
(74 %)
35 diff
(96.7 %id)
BE926983 colon_normal .a-u 684 to 781 98 to 2       97/112
(86 %)
0 diff
(100 %id)
BU157061 epithelioid carcinoma, Pancreas .a-u 687 to 1310 28 to 654       627/946
(66 %)
8 diff
(99.2 %id)
CN335047 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 691 to 1072 1 to 382       382/382
(100 %)
0 diff
(100 %id)
TI_149295960   .a-u 693 to 1433 871 to 137   AAA   735/904
(81 %)
59 diff
(93.5 %id)
AA837505 epithelium (cell line), Prostate .a-u 700 to 1433 731 to 1       731/917
(79 %)
20 diff
(97.9 %id)
BM977397 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 714 to 1433 738 to 19   AAA   720/720
(100 %)
0 diff
(100 %id)
CA311322 Human Lung Epithelial cells, lung .a-u 716 to 1433 742 to 19   AAA   724/724
(100 %)
2 diff
(99.8 %id)
BQ376705 uterus .a-u 721 to 936 9 to 229       221/250
(88 %)
13 diff
(94.8 %id)
CA432447 cell lines, Chondrosarcoma .a-u 721 to 1433 733 to 19   AAA   715/715
(100 %)
1 diff
(99.9 %id)
BU633398 cell lines, Chondrosarcoma .a-u 725 to 1433 729 to 19   AAA   711/711
(100 %)
1 diff
(99.9 %id)
AW579542 head_neck .a-u 728 to 854 129 to 1       129/129
(100 %)
3 diff
(97.7 %id)
CN335044 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 729 to 1130 1 to 404       404/404
(100 %)
2 diff
(99.6 %id)
BF220247 lung, small cell carcinoma .a-u 738 to 1386 670 to 2       669/713
(93 %)
0 diff
(100 %id)
BG946406 bladder_tumor .a-u 749 to 950 203 to 1       203/205
(99 %)
9 diff
(95.7 %id)
BF916606 uterus_tumor .a-u 751 to 877 1 to 127       127/137
(92 %)
8 diff
(94.2 %id)
BG993129 head_neck .a-u 753 to 880 130 to 1       130/130
(100 %)
6 diff
(95.4 %id)
TI_149297296   .a-u 757 to 1433 764 to 91   AAA   674/702
(96 %)
3 diff
(99.6 %id)
TI_149313014   .a-u 759 to 1433 752 to 86   AAA   667/866
(77 %)
29 diff
(96.7 %id)
BM982185 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 773 to 1433 683 to 19   AAA   665/665
(100 %)
2 diff
(99.7 %id)
BM982387 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 775 to 1433 676 to 19   AAA   658/658
(100 %)
1 diff
(99.9 %id)
BM976949 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 783 to 1433 664 to 19   AAA   646/646
(100 %)
6 diff
(99.1 %id)
BU629819 cell lines, Chondrosarcoma .a-u 783 to 1433 671 to 19   AAA   653/653
(100 %)
2 diff
(99.7 %id)
BU631549 cell lines, Chondrosarcoma .a-u 783 to 1433 671 to 19   AAA   653/653
(100 %)
1 diff
(99.9 %id)
BU631801 cell lines, Chondrosarcoma .a-u 783 to 1433 670 to 19   AAA   652/652
(100 %)
4 diff
(99.4 %id)
CA432639 cell lines, Chondrosarcoma .a-u 783 to 1433 671 to 19   AAA   653/653
(100 %)
2 diff
(99.7 %id)
CN478851 Human Lung Epithelial cells, lung .a-u 787 to 1433 662 to 19   AAA   644/644
(100 %)
6 diff
(99.1 %id)
W81148 heart .a-u 791 to 1051 1 to 264   fully sequenced,   264/264
(100 %)
6 diff
(97.8 %id)
BU608432 Human Lung Epithelial cells, lung .a-u 803 to 1433 651 to 19   AAA   633/633
(100 %)
2 diff
(99.7 %id)
TI_159723239   .a-u 804 to 1433 720 to 84   AAA   637/1009
(63 %)
13 diff
(98.8 %id)
CB242652 Human Lung Epithelial cells, lung .a-u 804 to 1433 655 to 19   AAA   637/645
(98 %)
13 diff
(98.0 %id)
BU620417 cell lines, Chondrosarcoma .a-u 804 to 1432 648 to 19   AAA   630/630
(100 %)
3 diff
(99.6 %id)
AI834243 head_neck .a-u 807 to 940 1 to 134       134/134
(100 %)
0 diff
(100 %id)
BM969249 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 842 to 1433 613 to 19   AAA   595/595
(100 %)
10 diff
(98.4 %id)
BM689034 eye, eye anterior segment .a-u 875 to 1228 1 to 354   fully sequenced,   354/354
(100 %)
5 diff
(98.6 %id)
AA584037 larynx .a-u 879 to 1433 549 to 8       542/553
(98 %)
0 diff
(100 %id)
BU732431 eye, optic nerve .a-u 901 to 1433 551 to 19   AAA   533/533
(100 %)
0 diff
(100 %id)
AA593934 colon, colon tumor .a-u 904 to 1432 526 to 1       526/526
(100 %)
8 diff
(98.5 %id)
AA641135 invasive tumor (cell line), Prostate .a-u 909 to 1403 495 to 1       495/587
(84 %)
34 diff
(94.3 %id)
BQ888515 ductal carcinoma, cell line, Pancreas .a-u 909 to 1338 1 to 430       430/1069
(40 %)
10 diff
(99.1 %id)
TI_151738655   .a-u 911 to 1433 623 to 96   AAA   528/528
(100 %)
5 diff
(99.1 %id)
AA586733 larynx .a-u 917 to 1319 397 to 1       397/397
(100 %)
41 diff
(89.7 %id)
AA838220 epithelium (cell line), Prostate .a-u 929 to 1433 508 to 7       502/508
(98 %)
0 diff
(100 %id)
AA837904 epithelium (cell line), Prostate .a-u 943 to 1403 459 to 1       459/459
(100 %)
10 diff
(97.9 %id)
AI283995 esophagus, squamous cell carcinoma .a-u 945 to 1433 484 to 1       484/526
(92 %)
23 diff
(95.7 %id)
AA552598 colon, tumor .a-u 950 to 1433 488 to 3       486/488
(99 %)
0 diff
(100 %id)
AA158556 Pancreas .a-u 951 to 1404 461 to 1       461/462
(99 %)
24 diff
(94.9 %id)
AI608618 normal gingiva (cell line from primarykeratinocytes) .a-u 955 to 1433 476 to 2       475/476
(99 %)
0 diff
(100 %id)
AW081937 esophagus, squamous cell carcinoma .a-u 960 to 1433 471 to 2       470/471
(99 %)
0 diff
(100 %id)
AW874282 tumor, uterus .a-u 961 to 1433 476 to 2       475/476
(99 %)
0 diff
(100 %id)
CN335033 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 962 to 1160 1 to 199       199/199
(100 %)
2 diff
(99.0 %id)
CF541079 lung .a-u 963 to 1433 497 to 19   AAA   479/479
(100 %)
3 diff
(99.4 %id)
AA513205 Prostate .a-u 965 to 1433 476 to 7       470/476
(98 %)
0 diff
(100 %id)
AA554950 lung, lung tumor .a-u 965 to 1305 341 to 1       341/341
(100 %)
16 diff
(95.4 %id)
AI356363 B-cell, chronic lymphotic leukemia .a-u 965 to 1433 471 to 4       468/471
(99 %)
0 diff
(100 %id)
BM673260 eye, eye anterior segment .a-u 965 to 1433 487 to 19   AAA   469/469
(100 %)
0 diff
(100 %id)
AI672841 colon, colonic mucosa from 3 patients with Crohn'sdisease .a-u 967 to 1433 470 to 4       467/470
(99 %)
0 diff
(100 %id)
AW950173   .a-u 971 to 1330 1 to 360       360/366
(98 %)
24 diff
(93.5 %id)
AA079732 Pancreas .a-u 975 to 1403 431 to 1       431/431
(100 %)
9 diff
(98.0 %id)
AA826814 invasive tumor (cell line), Prostate .a-u 975 to 1403 429 to 1       429/430
(99 %)
19 diff
(95.6 %id)
AW085653 esophagus, squamous cell carcinoma .a-u 983 to 1433 452 to 4       449/452
(99 %)
0 diff
(100 %id)
AW269520 lung, two pooled squamous cell carcinomas .a-u 983 to 1433 449 to 2       448/449
(99 %)
0 diff
(100 %id)
BF439669 pooled .a-u 988 to 1426 441 to 1       441/443
(99 %)
3 diff
(99.4 %id)
CN335040 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 989 to 1433 457 to 11   AAA Submitted on the opposite strand 447/447
(100 %)
7 diff
(98.5 %id)
AA533175 normal prostatic epithelial cells, Prostate .a-u 991 to 1437 8 to 456       449/500
(89 %)
6 diff
(98.8 %id)
AI969260 lung, two pooled squamous cell carcinomas .a-u 995 to 1433 445 to 11   AAA   435/435
(100 %)
2 diff
(99.6 %id)
AW117948 esophagus, squamous cell carcinoma .a-u 995 to 1418 422 to 1       422/422
(100 %)
3 diff
(99.3 %id)
AW268370 lung, two pooled squamous cell carcinomas .a-u 996 to 1433 450 to 11   AAA   440/440
(100 %)
1 diff
(99.8 %id)
BF198139 skin, normal, 4 pooled samples .a-u 1002 to 1433 433 to 2       432/435
(99 %)
0 diff
(100 %id)
AA858392 pharynx, squamous cell carcinoma .a-u 1007 to 1403 396 to 1       396/396
(100 %)
22 diff
(94.5 %id)
AW273771 lung, two pooled squamous cell carcinomas .a-u 1011 to 1433 431 to 7       425/431
(98 %)
0 diff
(100 %id)
AI354364 esophagus, squamous cell carcinoma .a-u 1013 to 1433 419 to 1       419/419
(100 %)
4 diff
(99.1 %id)
AW250794 lung, small cell carcinoma .a-u 1013 to 1433 427 to 11   AAA   417/417
(100 %)
3 diff
(99.3 %id)
BU737526 eye, lens .a-u 1013 to 1433 435 to 19   AAA   417/417
(100 %)
2 diff
(99.6 %id)
W74461 heart .a-u 1015 to 1433 414 to 1       414/414
(100 %)
6 diff
(98.6 %id)
AA064650 Pancreas .a-u 1020 to 1404 389 to 1       389/391
(99 %)
15 diff
(96.2 %id)
AW191846 adenocarcinoma, Pancreas .a-u 1020 to 1433 414 to 13   AAA   402/405
(99 %)
15 diff
(96.3 %id)
W81149 heart .a-u 1021 to 1434 420 to 1   fully sequenced,   420/420
(100 %)
19 diff
(95.5 %id)
AI864911 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a-u 1021 to 1433 441 to 25   AAA   417/417
(100 %)
3 diff
(99.3 %id)
BX327979 Placenta Cot 25-normalized .a-u 1023 to 1332 16 to 323       308/1040
(29 %)
2 diff
(99.9 %id)
AW050960 colon, colonic mucosa from 3 patients with Crohn'sdisease .a-u 1027 to 1433 411 to 3       409/411
(99 %)
0 diff
(100 %id)
AW087957 esophagus, squamous cell carcinoma .a-u 1028 to 1433 404 to 3       402/412
(97 %)
0 diff
(100 %id)
AI802687 colon, colonic mucosa from 5 ulcerative colitispatients .a-u 1029 to 1433 403 to 3       401/403
(99 %)
0 diff
(100 %id)
BM687748 eye, eye anterior segment .a-u 1030 to 1426 9 to 404       396/404
(98 %)
6 diff
(98.6 %id)
AW780270 colon, moderately-differentiated adenocarcinoma .a-u 1032 to 1433 408 to 5       404/408
(99 %)
0 diff
(100 %id)
BQ349166 head_neck .a-u 1050 to 1186 8 to 142       135/159
(84 %)
3 diff
(98.2 %id)
AI474308 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a-u 1051 to 1433 391 to 10       382/391
(97 %)
0 diff
(100 %id)
CN335041 embryonic stem cells, DMSO-treated H9 cellline .a-u 1053 to 1430 141 to 518       500/518
(96 %)
10 diff
(98.1 %id)
AA639425 colon, colon tumor RER+ .a-u 1058 to 1302 245 to 1       245/245
(100 %)
6 diff
(97.6 %id)
AW516830 cervix, tumor .a-u 1058 to 1302 256 to 12       245/256
(95 %)
0 diff
(100 %id)
BM672807 eye, optic nerve .a-u 1065 to 1438 387 to 14   fully sequenced,   374/387
(96 %)
7 diff
(98.2 %id)
AW117923 esophagus, squamous cell carcinoma .a-u 1075 to 1433 364 to 3       362/364
(99 %)
0 diff
(100 %id)
AI857657 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a-u 1077 to 1288 212 to 1       212/212
(100 %)
8 diff
(96.3 %id)
AW615768 lung, small cell carcinoma .a-u 1077 to 1430 353 to 4       350/353
(99 %)
0 diff
(100 %id)
AW170288 cervix, tumor .a-u 1080 to 1429 358 to 11   AAA   348/348
(100 %)
15 diff
(95.7 %id)
BF850208 lung_normal .a-u 1081 to 1420 340 to 1     Submitted on the opposite strand 340/358
(94 %)
13 diff
(96.4 %id)
AI354963 esophagus, squamous cell carcinoma .a-u 1086 to 1433 363 to 20   AAA   344/344
(100 %)
6 diff
(98.3 %id)
AW050763 colon, colonic mucosa from 3 patients with Crohn'sdisease .a-u 1091 to 1433 355 to 10       346/355
(97 %)
0 diff
(100 %id)
AW004962 colon .a-u 1103 to 1433 340 to 2       339/340
(99 %)
0 diff
(100 %id)
AA662510 normal prostate, Prostate .a-u 1106 to 1433 325 to 3       323/325
(99 %)
0 diff
(100 %id)
BM788902 stomach .a-u 1107 to 1433 1 to 327   AAA   327/327
(100 %)
3 diff
(99.1 %id)
AI611709 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a-u 1109 to 1418 308 to 1       308/309
(99 %)
25 diff
(92.0 %id)
AW117738 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a-u 1123 to 1419 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AW079623 esophagus, squamous cell carcinoma .a-u 1135 to 1433 308 to 1       308/335
(91 %)
5 diff
(98.6 %id)
AW272971 lung, two pooled squamous cell carcinomas .a-u 1138 to 1418 279 to 1       279/283
(98 %)
10 diff
(96.5 %id)
AA642581 normal prostate, Prostate .a-u 1141 to 1303 15 to 177     Submitted on the opposite strand 163/177
(92 %)
6 diff
(96.7 %id)
AW383834 head_neck .a-u 1143 to 1343 210 to 10       201/210
(95 %)
0 diff
(100 %id)
BU535155 mixed (pool of 40 RNAs) .a-u 1143 to 1433 1 to 289       289/293
(98 %)
3 diff
(99.0 %id)
BF868808 lung_tumor .a-u 1151 to 1424 278 to 9     Submitted on the opposite strand 270/310
(87 %)
0 diff
(100 %id)
AW801049 uterus .a-u 1152 to 1371 15 to 235       221/246
(89 %)
9 diff
(96.4 %id)
AW265603 moderate to poorly differentiated invasivecarcinoma, tongue .a-u 1178 to 1433 255 to 2       254/255
(99 %)
0 diff
(100 %id)
AI832277 colon .a-u 1194 to 1433 236 to 1       236/236
(100 %)
4 diff
(98.4 %id)
BU727219 eye, eye anterior segment .a-u 1198 to 1438 252 to 14   fully sequenced,   239/252
(94 %)
6 diff
(97.7 %id)
AA595966 larynx .a-u 1201 to 1403 202 to 1       202/202
(100 %)
3 diff
(98.6 %id)
BM672430 eye, optic nerve .a-u 1202 to 1433 248 to 19   AAA   230/230
(100 %)
1 diff
(99.6 %id)
CN277867 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 1255 to 1433 1 to 181   AAA   181/181
(100 %)
6 diff
(96.7 %id)
AA922403 squamous cell carcinoma from base of tongue, tongue .a-u 1336 to 1433 132 to 34   AAA   99/99
(100 %)
3 diff
(97.0 %id)
BP227470   .b 1 to 555 1 to 557   tiling clone,   557/581
(95 %)
7 diff
(98.8 %id)
AA191264   .b 7 to 196 1 to 190       190/197
(96 %)
5 diff
(97.5 %id)
AA191692   .b 444 to 1070 617 to 4   tiling clone,   614/618
(99 %)
0 diff
(100 %id)
AA308350 colon Gene SFN, variant not shown         Suspected internal deletion, this clone was ignored    
BC001550 Cervix, carcinoma Gene SFN, variant not shown       available from MGC, AAA This clone was ignored    
BI010325 lung_normal Gene SFN, variant not shown         Suspected internal deletion, this clone was ignored    
CV024907 mixed Gene SFN, variant not shown         This clone was ignored    
AA613438 colon, colon tumor RER+ Gene SFN, variant not shown         Suspected internal deletion, this clone was ignored    
BE543687 cervical carcinoma cell line, cervix Gene SFN, variant not shown         This clone was ignored    
TI_1948100301   Gene SFN, variant not shown         This clone was ignored    
TI_1948100453   Gene SFN, variant not shown         This clone was ignored    
TI_1948100454   Gene SFN, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a-u, .b Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI